Circulating mSEPT9 Biomarker Testing clinical trials

mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis

This study looks at a new blood test called mSEPT9 to predict liver cancer (HCC) in people with cirrhosis. We're hoping it can help doctors find liver cancer earlier and tailor treatment plans better for each person.